Фото: Виталий Белоусов / РИА Новости
With the influx of “new drug applications” taking up a larger percentage of labor hours, the FDA had to turn to some other alternatives for help. The agency already has a program in place from the 1990s, called the Prescription Drug User Fee Act (PDUFA), which outlines the guidelines and metrics for the FDA to review a drug. Drug companies pay significant fees to the agency when submitting their applications, which now totals more than $2.8 trillion for trials involving clinical data.。电影对此有专业解读
With that said, there are some new features and improvements that are not just about alignment.，详情可参考PDF资料
After weeks of failed negotiations, public ultimatums, and lawsuit threats, the Defense Department has formally labeled Anthropic a "supply-chain risk", escalating its fight with the AI company over their acceptable use policies and potentially bringing their fight to court.